Middle East and Africa In-Vitro Diagnostics Market Segments and Growth by 2027

The In-vitro diagnostics market in Middle East and Africa is expected to grow from US$ 2,675.1 million in 2019 to US$ 3,454.0 million by 2027; it is estimated to grow at a CAGR of 3.2% from 2020 to 2027.

Automation deals with the utilization of various intelligent systems with an aim to perform any operation with minimal human intervention. The application of automation in clinical laboratories enables analysts to perform several tests in minimum turnaround time and efforts. Moreover, the automation can serve maximum accuracy in results as well as reduction in variations. Additionally, installation of intelligent software & hardware in clinical analyzers has dramatically improved the overall operating capacity, quality of data processing, and process control in clinical automation. Extensively increasing patient pool is generating massive demand for clinical automation as it offers superior benefits. For instance, in May 2019, Beckman Coulter, one of the major market players announced introduction of its new DxA 5000 total laboratory automation solution. The newly launched system is capable of managing high volume samples with significant reduction in procedural time. Furthermore, growing emphasis of healthcare institutes on cost and time optimization is fueling the adoption of automation in clinical laboratories. Additionally, increasing focus on error reduction, efficient sample collection, and patient safety would eventually boost the acceptance of laboratory automation during the forecast period.

Thecountries in the Middle East and African region have taken precautionary measures and imposed stringent regulations to control the spread of COVID-19. Countries such

as

UAE, Saudi Arabia, Jordan, Iraq, and Iran, have strictly imposed lockdown in the countries. The majority of the countries in the region are dependent on the other region for medical devices and other products. Therefore, there has been a shortage of various test kits in some countries. However, various international organizations such as International Federation for Red Cross, Red Crescent, and the United Nations Volunteers (UNV) program have helped in a great way to provide IVD facilities in all possible ways. Various European companies have been supporting by offering their rapid immunochemistry test. The import of rapid test kits has increased growth opportunities for various companies to expand their business in the region. Also, the growing developments for the healthcare industry in the region are likely to foster growth in the following years.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the In-vitro diagnostics market. The Middle East and Africa In-vitro diagnostics market is expected to grow at a good CAGR during the forecast period.

 

Middle East and Africa In-Vitro Diagnostics Market Segmentation      

By Product and Services

• Instruments
• Reagents & Kits
• Software & Services

By Technology

• Immunoassay/ Immunochemistry
• Clinical Chemistry
• Molecular Diagnostics
• Microbiology
• Blood Glucose Self-Monitoring
• Coagulation & Hemostasis
• Hematology
• Urinalysis
• Others

By Application

• Infectious Diseases
• Diabetes
• Oncology
• Cardiology
• Autoimmune Diseases
• Nephrology
• Others

By End User

• Hospitals
• Laboratories
• Homecare
• Others

By Country

• Middle East and Africa

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Companies Mentioned

• F. HOFFMANN-LA ROCHE LTD.
• DANAHER
• ABBOTT
• SIEMENS AG
• SYSMEX CORPORATION
• THERMO FISHER SCIENTIFIC, INC.
• BD
• BIOMERIEUX SA
• BIO-RAD LABORATORIES, INC.
• QIAGEN

Middle East and Africa In-Vitro Diagnostics Report Scope